CD34 and neoplasm: Furthermore, the IHC test indicated that administration of tRF‐34‐antagomir also suppressed the expression levels of Ki‐67, N‐cadherin, Vimentin, and CD34 protein levels and increased the expression levels of DAB2IP and E‐cadherin in the xenograft tumour tissues (Figure 7E).